Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. 2009

Lin Lin, and Ashraf S Ibrahim, and Xin Xu, and Joshua M Farber, and Valentina Avanesian, and Beverlie Baquir, and Yue Fu, and Samuel W French, and John E Edwards, and Brad Spellberg
The Division of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-University of California at Los Angeles Medical Center, Torrance, California, USA.

We sought to define protective mechanisms of immunity to Staphylococcus aureus and Candida albicans bloodstream infections in mice immunized with the recombinant N-terminus of Als3p (rAls3p-N) vaccine plus aluminum hydroxide (Al(OH(3)) adjuvant, or adjuvant controls. Deficiency of IFN-gamma but not IL-17A enhanced susceptibility of control mice to both infections. However, vaccine-induced protective immunity against both infections required CD4+ T-cell-derived IFN-gamma and IL-17A, and functional phagocytic effectors. Vaccination primed Th1, Th17, and Th1/17 lymphocytes, which produced pro-inflammatory cytokines that enhanced phagocytic killing of both organisms. Vaccinated, infected mice had increased IFN-gamma, IL-17, and KC, increased neutrophil influx, and decreased organism burden in tissues. In summary, rAls3p-N vaccination induced a Th1/Th17 response, resulting in recruitment and activation of phagocytes at sites of infection, and more effective clearance of S. aureus and C. albicans from tissues. Thus, vaccine-mediated adaptive immunity can protect against both infections by targeting microbes for destruction by innate effectors.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D002177 Candidiasis Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed) Candida Infection,Moniliasis,Candida Infections,Candidiases,Infection, Candida,Moniliases
D005260 Female Females
D005656 Fungal Proteins Proteins found in any species of fungus. Fungal Gene Products,Fungal Gene Proteins,Fungal Peptides,Gene Products, Fungal,Yeast Proteins,Gene Proteins, Fungal,Peptides, Fungal,Proteins, Fungal
D005657 Fungal Vaccines Suspensions of attenuated or killed fungi administered for the prevention or treatment of infectious fungal disease. Vaccines, Fungal
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000536 Aluminum Hydroxide A compound with many biomedical applications: as a gastric antacid, an antiperspirant, in dentifrices, as an emulsifier, as an adjuvant in bacterins and vaccines, in water purification, etc. Hydrated Alumina,Aldrox,Algeldrate,Alhydrogel,Alugel,Amphojel,Basalgel,Brasivil,Dialume,Nephrox,Pepsamer,Rocgel,Alumina, Hydrated,Hydroxide, Aluminum

Related Publications

Lin Lin, and Ashraf S Ibrahim, and Xin Xu, and Joshua M Farber, and Valentina Avanesian, and Beverlie Baquir, and Yue Fu, and Samuel W French, and John E Edwards, and Brad Spellberg
June 2011, Blood,
Lin Lin, and Ashraf S Ibrahim, and Xin Xu, and Joshua M Farber, and Valentina Avanesian, and Beverlie Baquir, and Yue Fu, and Samuel W French, and John E Edwards, and Brad Spellberg
May 2012, Cell host & microbe,
Lin Lin, and Ashraf S Ibrahim, and Xin Xu, and Joshua M Farber, and Valentina Avanesian, and Beverlie Baquir, and Yue Fu, and Samuel W French, and John E Edwards, and Brad Spellberg
January 2017, Current topics in microbiology and immunology,
Lin Lin, and Ashraf S Ibrahim, and Xin Xu, and Joshua M Farber, and Valentina Avanesian, and Beverlie Baquir, and Yue Fu, and Samuel W French, and John E Edwards, and Brad Spellberg
January 2015, PLoS pathogens,
Lin Lin, and Ashraf S Ibrahim, and Xin Xu, and Joshua M Farber, and Valentina Avanesian, and Beverlie Baquir, and Yue Fu, and Samuel W French, and John E Edwards, and Brad Spellberg
January 2022, Frontiers in immunology,
Lin Lin, and Ashraf S Ibrahim, and Xin Xu, and Joshua M Farber, and Valentina Avanesian, and Beverlie Baquir, and Yue Fu, and Samuel W French, and John E Edwards, and Brad Spellberg
September 2013, Mucosal immunology,
Lin Lin, and Ashraf S Ibrahim, and Xin Xu, and Joshua M Farber, and Valentina Avanesian, and Beverlie Baquir, and Yue Fu, and Samuel W French, and John E Edwards, and Brad Spellberg
May 1976, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie,
Lin Lin, and Ashraf S Ibrahim, and Xin Xu, and Joshua M Farber, and Valentina Avanesian, and Beverlie Baquir, and Yue Fu, and Samuel W French, and John E Edwards, and Brad Spellberg
July 2011, The Journal of infectious diseases,
Lin Lin, and Ashraf S Ibrahim, and Xin Xu, and Joshua M Farber, and Valentina Avanesian, and Beverlie Baquir, and Yue Fu, and Samuel W French, and John E Edwards, and Brad Spellberg
April 2004, Immunology and cell biology,
Lin Lin, and Ashraf S Ibrahim, and Xin Xu, and Joshua M Farber, and Valentina Avanesian, and Beverlie Baquir, and Yue Fu, and Samuel W French, and John E Edwards, and Brad Spellberg
November 2012, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!